Synthesis and Evaluation of Folate-Conjugated Phenanthraquinones for Tumor-Targeted Oxidative Chemotherapy
Open Access
- 1 January 2016
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Open Journal of Medicinal Chemistry
- Vol. 06 (01), 1-17
- https://doi.org/10.4236/ojmc.2016.61001
Abstract
Almost all cells are easily killed by exposure to potent oxidants. Indeed, major pathogen defense mechanisms in both animal and plant kingdoms involve production of an oxidative burst, where host defense cells show an invading pathogen with reactive oxygen species (ROS). Although cancer cells can be similarly killed by ROS, development of oxidant-producing chemotherapies has been limited by their inherent nonspecificity and potential toxicity to healthy cells. In this paper, we describe the targeting of an ROS-generating molecule selectively to tumor cells using folate as the tumor-targeting ligand. For this purpose, we exploit the ability of 9,10-phenanthraquinone (PHQ) to enhance the continuous generation of H2O2 in the presence of ascorbic acid to establish a con-stitutive source of ROS within the tumor mass. We report here that incubation of folate receptor-expressing KB cells in culture with folate-PHQ plus ascorbate results in the death of the cancer cells with an IC50 of ~10 nM (folate-PHQ). We also demonstrate that a cleavable spacer linking folate to PHQ is significantly inferior to a noncleavable spacer, in contrast to most other folate-targeted therapeutic agents. Unfortunately, no evidence for folate-PHQ mediated tumor regression in murine tumor models is obtained, suggesting that unanticipated impediments to generation of cytotoxic quantities of ROS in vivo are encountered. Possible mechanisms and potential solutions to these unanticipated results are offered.Keywords
This publication has 56 references indexed in Scilit:
- How does the oxidative burst of macrophages kill bacteria? Still an open questionMolecular Microbiology, 2011
- Vitamin C: A Concentration-Function Approach Yields Pharmacology and Therapeutic DiscoveriesAdvances in Nutrition: An International Review Journal, 2011
- Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic CancerClinical Cancer Research, 2010
- High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesisJournal of Translational Medicine, 2009
- Losing and finding a way at C: New promise for pharmacologic ascorbate in cancer treatmentFree Radical Biology & Medicine, 2009
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in miceProceedings of the National Academy of Sciences of the United States of America, 2008
- Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivoProceedings of the National Academy of Sciences of the United States of America, 2007
- Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imagingProceedings of the National Academy of Sciences of the United States of America, 2006
- The role of reactive oxygen and nitrogen species in cellular iron metabolismFree Radical Research, 2006
- REACTIVE OXYGEN SPECIES: Metabolism, Oxidative Stress, and Signal TransductionAnnual Review of Plant Biology, 2004